Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04316533
What this trial is testing

Work Stress and Impact of Pruritus on Quality of Life

Who this might be right for
Psoriasis
University Hospital, Brest 30
Not applicableStudy completedNCT06172426
What this trial is testing

Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry

Who this might be right for
Psoriatic ArthritisPsoriasis
Novartis Pharmaceuticals 1,171
Not applicableStudy completedNCT04293718
What this trial is testing

Acquired Chronic Erosive Gingivitis: Clinical Relevance of Papillary Gingival Biopsy

Who this might be right for
Gingival DiseasesGingivitisAutoimmune Diseases+1 more
Assistance Publique - Hôpitaux de Paris 100
Post-approval studies (Phase 4)Study completedNCT00332332
What this trial is testing

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

Who this might be right for
Psoriasis
Amgen 246
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT07839455
What this trial is testing

Oral and Topical Phytocannabinoids for Psoriasis

Who this might be right for
Psoriasis Vulgaris
Federal University of Latin American Integration 37
Post-approval studies (Phase 4)Study completedNCT04193748
What this trial is testing

Evaluation of Topical Pomegranate Extracts in Management of Oral Lichen Planus (A Randomized Clinical Trial)

Who this might be right for
Oral Lichen Planus
Cairo University 42
Early research (Phase 1)Study completedNCT04316585
What this trial is testing

Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

Who this might be right for
Psoriasis
GlaxoSmithKline 29
Not applicableUnknownNCT05598684
What this trial is testing

SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

Who this might be right for
Crohn DiseaseUlcerative ColitisRheumatoid Arthritis+2 more
Fresenius Kabi, France 600
Post-approval studies (Phase 4)Study completedNCT01553058
What this trial is testing

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Who this might be right for
PsoriasisCardiovascular Disease
University of Pennsylvania 97
Testing effectiveness (Phase 2)Ended earlyNCT05715125
What this trial is testing

VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

Who this might be right for
Psoriatic Arthritis
Ventyx Biosciences, Inc 205
Post-approval studies (Phase 4)Study completedNCT02858713
What this trial is testing

Adherence in Topical Treatment of Psoriasis

Who this might be right for
Adherence
Odense University Hospital 134
Early research (Phase 1)Study completedNCT01563068
What this trial is testing

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 18
Not applicableStudy completedNCT05251220
What this trial is testing

Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women

Who this might be right for
Genitourinary Syndrome of MenopausePelvic Floor DysfunctionVulvar Lichen Sclerosus
1st Federal Budgetary Healthcare Institution Volga District Medical Center 60
Large-scale testing (Phase 3)UnknownNCT04071106
What this trial is testing

Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial

Who this might be right for
Psoriasis
Zagazig University 50
Large-scale testing (Phase 3)Study completedNCT02635204
What this trial is testing

The Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Promius Pharma, LLC 267
Testing effectiveness (Phase 2)Ended earlyNCT01516957
What this trial is testing

AMG 827 in Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Bausch Health Americas, Inc. 168
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Not applicableStudy completedNCT00884468
What this trial is testing

Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer 384
Early research (Phase 1)Looking for participantsNCT06376474
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 24
Next Page